Adenosine receptor targets for pain

Neuroscience

Volumn 338, Issue , 2016, Pages 1-18

  Sawynok, J ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

acupuncture; adenosine; antinociception; caffeine; inflammatory pain; neuropathic pain

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 AMINO 5 (3 BROMOPHENYL) 7 (6 MORPHOLINO 3 PYRIDINYL)PYRIDO[2,3 D]PYRIMIDINE; 6 N (2 HYDROXYCYCLOPENTYL)ADENOSINE; ACETYLSALICYLIC ACID; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE KINASE; ADENOSINE RECEPTOR; AMITRIPTYLINE; CAFFEINE; ETANERCEPT; EVODENOSON; GABAPENTIN; GW 493838; HERBACEOUS AGENT; IBUPROFEN; METHOTREXATE; MORPHINE; PARACETAMOL; PICLIDENOSON; ANALGESIC AGENT;

ACUPUNCTURE; ADJUVANT ARTHRITIS; ADJUVANT THERAPY; ALLODYNIA; ANALGESIC ACTIVITY; ANTINOCICEPTION; ARTHRITIS; ASTROCYTE; BONE PAIN; CANCER PAIN; CHRONIC PAIN; COFFEE; COLLAGEN-INDUCED ARTHRITIS; COMPLEX REGIONAL PAIN SYNDROME; CYTOKINE RELEASE; DIABETIC NEUROPATHY; DRUG SELECTIVITY; EXERCISE; GLIA CELL; HUMAN; HYPERALGESIA; INFLAMMATORY DISEASE; INFLAMMATORY PAIN; JOINT MOBILIZATION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAIN; POSTOPERATIVE PAIN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; TOOTH PAIN; TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION; ANIMAL; METABOLISM;

ANALGESICS, NON-NARCOTIC; ANIMALS; HUMANS; PAIN; RECEPTORS, PURINERGIC P1;

EID: 84953238526     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.10.031     Document Type: Review

References (203)

1. Abed, A., Hajhashemi, V., Banafshe, H.R., Minaiyan, M., Mesdaghinia, Venlafaxine attenuates heat hyperalgesia independent of adenosine or opioid system in a rat model of peripheral neuropathy. Iran J Pharmaceut Res 14 (2015), 843–850.
2. 2B adenosine receptor antagonists. J Pharmacol Exp Ther 208 (2004), 358–366.
3. Ackley, M.A., Governo, R.J.M., Cass, C.E., Young, J.D., Baldwin, S.A., King, A.E., Control of glutamatergic neurotransmission in the rat spinal dorsal horn by nucleoside transporter ENT1. J Physiol 548 (2003), 507–517.
4. Antonioli, L., Blandizzi, C., Pacher, P., Hasko, G., Immunity, inflammation and cancer: a leading role for adenosine. Nat Rev Cancer 13 (2013), 842–857.
5. Antonioli, L., Csóka, B., Fornai, M., Colucci, R., Kókai, E., Blandizzi, C., Haskó, G., Adenosine and inflammation: what's new on the horizon?. Drug Discovery Today 19 (2014), 1051–1068.
6. Aubel, B., Kayser, V., Farré, A., Hamon, M., Bourgoin, S., Evidence for adenosine- and serotonin-mediated antihyperalgesic effects of cizolirtine in rats suffering from diabetic neuropathy. Neuropharmacol 52 (2007), 487–496.
7. Bagley, E.E., Vaughan, C.W., Christie, M.J., Inhibition by adenosine receptor agonists of synaptic transmission in rat periaqueductal grey neurons. J Physiol 516 (1999), 219–225.
8. Bantel, C., Li, X., Eisehach, J.C., Intraspinal adenosine induces spinal cord norepinephrine release in spinal nerve-ligated rats but not in normal or sham controls. Anesthesiology 98 (2003), 1461–1466.
9. 2A adenosine receptor ligands in mouse acute models of pain. Neurosci Lett 328 (2002), 241–244.
10. Benito-Garcia, E., Heller, J.E., Chibnik, L.B., Maher, N.E., Matthews, H.M., Bilics, J.A., Weinblatt, M.E., Shadick, N.A., Dietary caffeine intake does not affect methotrexate efficacy in patients with rheumatoid arthritis. J Rheumatol 33 (2006), 1275–1281.
11. Bilkei-Gorzo, A., Abo-Salem, O.M., Hayallah, A.M., Michel, K., Müller, C.F., Zimmer, A., Adenosine receptor subtype-selective antagonists in inflammation and hyperalgesia. Naunyn-Schmiedeberg's Arch Pharmacol 377 (2008), 65–76.
12. Boison, D., Adenosine kinase: exploitation for therapeutic gain. Pharmacol Rev 65 (2013), 906–943.
13. Boison, D., Chen, J.F., Fredholm, B.B., Adenosine signaling and function in glial cells. Cell Death Differ 17 (2010), 1071–1082.
14. 3 adenosine receptor: history and perspectives. Pharmacol Rev 67 (2014), 74–102.
15. 2A adenosine agonists in mice. Brain Res 956 (2002), 339–348.
16. Boyce, A., Amoateng, P., Koffuor, G.A., Barku, V.Y.A., Bawa, E.M., Anto, O.E., Antinociceptive and antioxidant activity of an aqueous root bark extract of Daniellia oliveri (Rolfe) Hutch. & Dalziel (Fam: Leguminosae [Fabaceae]) in ICR mice. J Appl Pharm Sci 3 (2013), 36–45.
17. 2A adenosine receptor regulates glia proliferation and pain after peripheral nerve injury. Pain 140 (2008), 95–103.
18. Chen, J.F., Eltzschig, H.K., Fredholm, B.B., Adenosine receptors as drug targets – what are the challenges?. Nature Rev Drug Discovery 12 (2013), 265–286.
19. Chen, J.F., Lee, C.F., Chern, Y., Adenosine receptor neurobiology: overview. Int Rev Neurobiol 119 (2014), 1–49.
20. 3 adenosine receptor activation. FASEB J 26 (2012), 1855–1865.
21. Choca, J.I., Green, R.D., Proudfit, H.K., Adenosine A1 and A2 receptors in the substantia gelatinosa are located predominantly on intrinsic neurons: an autoradiography study. J Pharmacol Exp Ther 247 (1988), 757–764.
22. Cohen, S., Barer, F., Bar-Yehuda, S., Ijzerman, A.P., Jacobson, K.A., Fishman, P., A3 adenosine receptor allosteric modulator induces an anti-inflammatory effect: in vivo studies and molecular mechanism of action. Mediators Inflamm, 2014, 10.1155/2014/708746 Article ID 708746.
23. 1 receptor agonist CPA in the absence and in the presence of spinal cord sensitization. Pharm Biochem Behav 82 (2005), 721–726.
24. Daenen, L., Varkey, E., Kellmann, M., Nijs, J., Exercise, not to exercise, or how to exercise in patients with chronic pain? Applying science to practice. Clin J Pain 31 (2015), 108–114.
25. DeLander, E.J., Hopkins, C.J., Spinal adenosine modulates descending antinociceptive pathways stimulated by morphine. J Pharmacol Exp Ther 239 (1986), 88–93.
26. DeLeo, J.A., Colburn, R.W., Rickman, A.J., Yaeger, M.P., Intrathecal catheterization alone induces neuroimmune activation in the rat. Eur J Pain 1 (1997), 115–122.
27. Derry, C.J., Derry, S., Moore, R.A., Caffeine as an analgesic adjuvant for acute pain in adults. Cochrane Database Syst Rev, 12, 2014, CD009281.
28. Dickenson, A., Suzuki, R., Reeve, A.J., Adenosine as a potential analgesic target in inflammatory and neuropathic pains. CNS Drugs 13 (2000), 77–85.
29. Doak, G.J., Sawynok, J., Complex role of peripheral adenosine in the genesis of response to subcutaneous formalin in the rat. Eur J Pharmacol 281 (1995), 311–318.
30. Eisenach, J.C., Hood, D.D., Curry, R., Sawynok, J., Yaksh, T.L., Li, X., Intrathecal but not intravenous opioids release adenosine from the spinal cord. J Pain 5 (2004), 64–68.
31. Essawy, S.S., Elbaz, A.A., Role of adenosine receptors in the anti-nociceptive effects of allopurinol in mice. Eur Rev Med Pharmacol Sci 17 (2013), 1857–1863.
32. Esser, M.J., Chase, T., Allen, G.V., Sawynok, J., Chronic administration of amitriptyline and caffeine in a rat model of neuropathic pain: multiple interactions. Eur J Pharmacol 430 (2001), 211–218.
33. Esser, M.J., Sawynok, J., Caffeine blockade of the thermal antihyperalgesic effect of acute amitriptyline in a rat model of neuropathic pain. Eur J Pharmacol 399 (2000), 131–139.
34. 3 adenosine receptor: sensitivity to hypoxic neurodegeneration. Cell Mol Neurobiol 23 (2003), 431–447.
35. 2B receptors in inflammation. Adv Pharmacol 61 (2011), 115–144.
36. Fillingim, R.B., King, C.D., Ribeiro-Dasilva, C., Rahim-Williams, B., Riley, J.L., Sex, gender and pain: a review of recent clinical and experimental findings. J Pain 10 (2009), 247–485.
37. 3 adenosine receptor agonists. Drug Discovery Today 17 (2012), 359–366.
38. 3AR agonists in neuropathic pain. J Neurosci 35 (2015), 6057–6067.
39. 1 adenosine receptor with antinociceptive effects in mice. J Med Chem 52 (2009), 2393–2406.
40. Fransen, M., McConnell, S., Harmer, A.R., Van der Esch, M., Simic, M., Bennell, K.L., Exercise for osteoarthritis of the knee. Cochrane Database Syst Rev, 1, 2015, CD004376.
41. Frary, C.D., Johnson, R.K., Wang, M.Q., Food sources and intakes of caffeine in the diets of persons in the United States. J Am Diet Assoc 105 (2005), 110–113.
42. Fredholm, B.B., Adenosine – a physiological or pathological agent?. J Mol Med 92 (2014), 201–206.
43. Fredholm, B.B., Bättig, K., Holmén, J., Nehlig, A., Zvartau, E.E., Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51 (1999), 83–133.
44. Fredholm, B.B., Ijzerman, A.P., Jacobson, K.A., Klotz, K.N., Linden, J., International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53 (2001), 527–552.
45. Fredholm, B.B., Ijzerman, A.P., Jacobson, K.A., Linden, J., Müller, C.E., International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of adenosine receptors – an update. Pharmacol Rev 63 (2011), 1–34.
46. Fukunaga, A.F., Alexander, G.E., Start, C.W., Characterisation of the analgesic action of adenosine: comparison of adenosine and remifentanil infusions in patients undergoing major surgical procedures. Pain 101 (2003), 129–138.
47. Gan, T.J., Habib, A.S., Adenosine as a non-opioid analgesic in the perioperative setting. Anesth Analg 105 (2007), 487–494.
48. 1 receptor. Eur J Pain 18 (2014), 939–948.
49. Gessi, S., Merighi, S., Fazzi, D., Stefanelli, A., Varani, K., Borea, P.A., Adenosine receptor targeting in health and disease. Expert Opin Investig Drug 20 (2011), 1591–1609.
50. 3 receptor: an enigmatic player in cell biology. Pharmac Ther 117 (2008), 123–140.
51. 2 receptor antagonists in mice. Eur J Pharmacol 531 (2006), 80–86.
52. Goldman, N., Chandler-Militello, D., Langevin, H.M., Nedergaard, M., Takano, T., Purine receptor mediated actin-cytoskeleton remodeling of human fibroblasts. Cell Calcium 53 (2013), 297–301.
53. Goldman, N., Chen, M., Fujita, T., Xu, Q., Peng, W., Liu, W., Jensen, T.K., Pei, Y., Wang, F., Han, X., Chen, J.F., Schnermann, J., Takano, T., Bekar, L., Tieu, K., Nedergaard, M., Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture. Nature Neurosci 13 (2010), 883–889.
54. Gomes, J.A., Li, X., Pan, H.L., Eisenach, J.C., Intrathecal adenosine interacts with a spinal noradrenergic system to produce antinociception in nerve-injured rats. Anesthesiology 91 (1999), 1072–1079.
55. 2A receptor blockade prevents BDNF release and proliferation of microglia. J Neuroinflamm, 10, 2013, 16, 10.1186/1742-2094-10-16.
56. 1 receptor on pain-related behavior in normal and nerve-injured rats. Brain Res 1361 (2010), 23–30.
57. Greenspan, J.D., Craft, R.M., LeResche, L., Arendt-Nielsen, L., Berkley, K.J., Fillingham, R.B., Gold, M.S., Holdcroft, A., Lautenbacher, S., Mayer, E.A., Mogil, J.S., Murphy, A.Z., Traub, R.J., Consensus working group on the sex, gender and pain SIG of the IASP. Studying sex and gender differences in pain and analgesia: a consensus report. Pain 132:Suppl. 1 (2007), S26–S45.
58. Guntz, E., Dumont, H., Pastijn, E., de Kerchove d'Exaerde, A., Azdad, K., Sosnowski, M., Schiffmann, S.N., Gall, D., Expression of adenosine A2A receptors in the rat lumbar spinal cord and implications in the modulation of N-methyl-D-aspartate receptor currents. Anesth Analg 106 (2008), 1882–1889.
59. Habib, A.S., Minkowitz, H., Osborn, T., Ogunnaike, B., Candiotti, K., Viscusi, E., Gu, J., Creed, M.R., Gan, T.J., Phase 2, double-blind, placebo-controlled, dose-response trial of intravenous adenosine for perioperative analgesia. Anesthesiology 109 (2008), 1085–1091.
60. Habib, M., Waheed, I., Evaluation of anti-nociceptive, anti-inflammatory and antipyretic activities of Artemisia scopario hydromethanolic extract. J Ethnopharmacol 145 (2013), 18–24.
61. 2B adenosine receptors in immunity and inflammation. Trends Immunol 30 (2009), 263–270.
62. Haskó, G., Linden, J., Cronstein, B., Pacher, P., Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nature Rev Drug Discovery 7 (2008), 759–770.
63. Hayashida, M., Fukuda, K., Fukunaga, A., Clinical application of adenosine and ATP for pain control. J Anesth 19 (2005), 225–235.
64. 1 receptor agonists reduce hyperalgesia after spinal cord injury in rats. Spinal cord 48 (2010), 685–690.
65. Hurt, J.K., Zylka, M.J., PAPupuncture has localized and long-lasting antinociceptive effects in mouse models of acute and chronic pain. Mol Pain, 8, 2012, 28, 10.1186/1744-8069-8-28.
66. 2A receptor knockout mice. Pain 129 (2007), 287–294.
67. 2A receptor in mice reduces the changes in spinal cord NMDA binding and glucose uptake caused by a nociceptive stimulus. Neurosci Lett 479 (2010), 297–301.
68. 2A receptor in mice enhances spinal cord neurochemical responses to an inflammatory nociceptive stimulus. Neurosci Lett 506 (2012), 198–202.
69. Jacobson, K.A., Gao, Z.G., Adenosine receptors as therapeutic targets. Nat Rev Drug Discovery 5 (2006), 247–264.
70. 3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways. Pain 155 (2014), 2560–2567.
71. 3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy. Brain Behav Immun 44 (2015), 91–99.
72. Ji, R.R., Berta, T., Nedergaard, M., Glia and pain: is chronic pain a gliopathy?. Pain 154:Suppl 1 (2013), S10–S28.
73. Kaelin-Lang, A., Lauterburg, T., Burgunder, J.M., Expression of adenosine A2a receptor gene in rat dorsal root and autonomic ganglia. Neurosci Lett 246 (1998), 21–24.
74. Kaelin-Lang, A., Lauterburg, T., Burgunder, J.M., Expression of adenosine A2a receptor gene in the olfactory bulb and spinal cord of rat and mouse. Neurosci Lett 261 (1999), 189–191.
75. 2A receptors in the motor effects of caffeine after its acute and chronic administration. Neuropsychopharmacol 28 (2003), 1281–1291.
76. Karunathilake, N.P., Frye, R.F., Stavropoulos, M.F., Herman, M.A., Hastie, B.A., A preliminary study of the effects of self-reported dietary caffeine on pain experience and postoperative analgesia. J Caff Res 2 (2012), 159–166.
77. 1 receptor agonist improves mechanical allodynia in a mouse model of painful diabetic neuropathy. Neuroscience 285 (2015), 312–323.
78. Keil, G.J., DeLander, G.E., Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine- and opioid agonist-induced antinociception in mice. Eur J Pharmacol 271 (1994), 37–46.
79. Kim, S.H., Stoicea, N., Soghomonvan, S., Bergese, S.D., Intraoperative use of remifentanil and opioid induced hyperalgesia/acute opioid tolerance: systematic review. Front Pharmacol, 8(5), 2014, 108, 10.3389/fphar.2014.00108.
80. 1-adenosine receptors: a review. Drug Disc Today: Technologies 10 (2013), e285–e296.
81. King, T., Vera-Portocarrero, L., Gutierrez, T., Vanderah, T.W., Dussor, G., Lai, J., Fields, H.L., Porreca, F., Unmasking the tonic-aversive state in neuropathic pain. Nat Neurosci 12 (2009), 1364–1366.
82. Khasar, S.G., Wang, J.F., Taiwo, Y.O., Heller, P.H., Green, P.G., Levine, J.D., Mu-opioid agonist enhancement of prostaglandin-induced hyperalgesia in the rat: a G-protein βγ subunit-mediated effect?. Neuroscience 67 (1995), 189–195.
83. Koltyn, K.F., Brellenthin, A.G., Cook, D.B., Sehgal, N., Hillard, C., Mechanisms of exercise-induced hypoalgesia. J Pain 15 (2014), 1294–1304.
84. 1 receptor agonists with antinociceptive effects in mice. J Med Chem 55 (2012), 6467–6477.
85. Langevin, H.M., Acupuncture, connective tissue, and peripheral sensory modulation. Crit Rev Eukaryot Gene Exp 24 (2014), 249–253.
86. Lao, L.J., Kawasaki, Y., Yang, K., Fujita, T., Kumamoto, E., Modulation by adenosine of Aδ and C primary-afferent glutamatergic transmission in adult rat substantia gelatinosa neurons. Neuroscience 125 (2004), 221–231.
87. 2a receptor. Nature 388 (1997), 674–678.
88. Lee, Y.W., Yaksh, T.L., Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists. J Pharmacol Exp Ther 277 (1996), 1642–1648.
89. Li, J., Perl, E.R., Adenosine inhibition of synaptic transmission in the substantia gelatinosa. J. Neurophysiol 72 (1994), 1611–1621.
90. 2A receptors are involved in carrageenan-induced mechanical hyperalgesia in mice. Neuroscience 170 (2010), 923–928.
91. Li, X., Bantel, C., Conklin, D., Childers, S.R., Eisenach, J.C., Repeated dosing with oral allosteric modulator of adenosine A1 receptor produces tolerance in rats with neuropathic pain. Anesthesiology 100 (2004), 956–961.
92. Li, X., Conklin, D., Ma, W., Zhu, X., Eisenach, J.C., Spinal noradrenergic activation mediates allodynia reduction from an allosteric adenosine modulator in a rat model of neuropathic pain. Pain 97 (2002), 117–125.
93. Li, X., Conklin, D., Pan, H.L., Eisenach, J.C., Allosteric adenosine receptor modulation reduces hypersensitivity following peripheral inflammation by a central mechanism. J Pharmacol Exp Ther 305 (2003), 950–955.
94. Li, X., Eisenach, J.C., Adenosine reduces glutamate release in rat spinal synaptosomes. Anesthesiology 103 (2005), 1060–1065.
95. Lima, F.O., Souza, G.R., Verri, W.A., Parada, C.A., Ferreira, S.H., Cunha, F.Q., Cunha, T.M., Direct blockade of inflammatory hypernociception by peripheral A1 adenosine receptors: involvement of the NO/cGMP/PKG/KATP signaling pathway. Pain 151 (2010), 506–515.
96. 3 receptor activation selectively alleviates persistent pain states. Brain 138 (2015), 28–35.
97. 1 receptors, are involved in antinociception by systemically administered amitriptyline. Eur J Pharmacol 698 (2013), 213–219.
98. 1 receptors. Neurosci Lett 536 (2013), 64–68.
99. Liu, X.J., White, T.D., Sawynok, J., Involvement of primary sensory afferents, postganglionic sympathetic nerves and mast cells in the formalin-evoked peripheral release of adenosine. Eur J Pharmacol 429 (2001), 147–155.
100. Loram, L.C., Harrison, J.A., Sloane, E.M., Hutchinson, M.R., Sholar, P., Taylor, F.R., Berkelhammer, D., Coats, B.D., Poole, S., Milligan, E.D., Maier, S.F., Rieger, J., Watkins, L.R., Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic pain. J Neurosci 29 (2009), 14015–14025.
101. Loram, L.C., Taylor, F.R., Strand, K.A., Harrison, J.A., Rzasalynn, R., Sholar, P., Rieger, J., Maier, S.F., Watkins, L.R., Intrathecal injection of adenosine 2A receptor agonists reversed neuropathic allodynia through protein kinase (PK)A/PKC signaling. Brain Behav Immun 33 (2013), 112–122.
102. Luchese, C., Prigol, M., Acker, C.I., Nogueira, C.W., Antinociceptive effect of butyl (2-phenylethynyl) selenide on formalin test in mice: evidences for the involvement of serotonergic and adenosinergic systems. Eur J Pharmacol 644 (2010), 49–54.
103. 1 adenosine receptor as a new player in microglia physiology. Glia 62 (2014), 122–132.
104. 1 receptor agonist, alleviates neuropathic pain in mice through functional glial and microglial changes without affecting motor or cardiovascular functions. Molecules 17 (2012), 13712–13726.
105. Lynch, M., Clark, A.J., Sawynok, J., Intravenous adenosine alleviates neuropathic pain. A double blind placebo controlled crossover trial using an enriched enrolment design. Pain 103 (2003), 111–117.
106. Maes, S.S., Pype, S., Hoffmann, V.L.H., Biermans, M., Meert, T.F., Antihyperalgesic activity of nucleoside transport inhibitors in models of inflammatory pain in guinea pigs. J Pain Res 5 (2012), 391–400.
107. Magni, G., Ceruti, S., The purinergic system and glial cells: Emerging costars in nociception. Biomed Res Int Article ID, 495789, 2014, 10.1155/2014/495789.
108. 1 receptor agonist, in the rat. Pain 131 (2007), 281–292.
109. Marchand, S., Li, J., Charest, J., Effects of caffeine on analgesia from transcutaneous electrical nerve stimulation. New Eng J Med 333 (1995), 325–326.
110. Marcondes Sari, M.H., Guerra Souza, A.C., Goncalves Rosa, S., Souza, D., Dorneles Rodrigues, O.E., Wayne Nogueira, C., Contribution of dopaminergic and adenosinergic systems in the antinociceptive effect of p-chloro-selenosteroid. Eur J Pharmacol 725 (2014), 79–86.
111. Martin, T.J., Kim, S.A., Buechler, N.L., Porreca, F., Eisenach, J.C., Opioid self-administration in the nerve-injured rat: relevance of antiallodynic effects to drug consumption and effects of intrathecal analgesics. Anesthesiology 106 (2007), 102–322.
112. 1 receptors. Phys Ther 93 (2013), 401–412.
113. Martins, D.F., Mazzardo-Martins, L., Soldi, F., Stramosk, J., Piovezan, A.P., Santos, A.R.S., High-intensity swimming exercise reduces neuropathic pain in an animal model of complex regional pain syndrome type I: evidence for a role of the adenosinergic system. Neuroscience 234 (2013), 69–76.
114. Martins, D.F., Brito, R.N., Stramosk, J., Batisti, A.P., Madeira, F., Turnes, B.L., Mazzardo-Martins, L., Santos, A.R.S., Piovezan, A.P., Peripheral neurobiologic mechanisms of antiallodynic effect of warm water immersion therapy on persistent inflammatory pain. J Neurosci Res 83 (2015), 157–166.
115. 1 receptor. J Peripher Nerv Syst, 2015 [Epub Oct 12, 2015b].
116. Mauborgne, A., Poliénor, H., Hamon, M., Cesselin, F., Bourgoin, S., Adenosine receptor-mediated control of in vitro release of pain-related neuropeptides from the rat spinal cord. Eur J Pharmacol 441 (2002), 47–55.
117. Mazzardo-Martins, Martins D.F., Marcon, R., Dos Santos, U.D., Speckhann, B., Gadotti, V.M., Sigwalt, A.R., Guglielmo, L.G., Santos, A.R., High-intensity extended swimming exercise reduces pain-related behaviour in mice: involvement of endogenous opioids and the serotonergic system. J Pain 11 (2010), 1384–1393.
118. Mazzon, E., Esposito, E., Impellizzeri, D., Di Paola, R., Melani, A., Bramanti, P., Pedata, F., Cuzzocrea, S., CGS21680, an agonist of the adenosine (A2A) receptor, reduces progression of murine type II collagen-induced arthritis. J Rheumatol 38 (2011), 2119–2129.
119. McGaraughty, S., Cowart, M., Jarvis, M.F., Berman, R.F., Anticonvulsant and antinociceptive actions of novel adenosine kinase inhibitors. Curr Topics Med Chem 5 (2005), 43–58.
120. McGaraughty, S., Jarvis, M.F., Purinergic control of neuropathic pain. Drug Dev Res 67 (2006), 376–388.
121. Milligan, E.D., Watkins, L.R., Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 10 (2009), 23–36.
122. Moré, A.O., Cidral-Filho, F., Mazzardo-Martins, L., Martins, D.F., Nascimento, F.P., Li, S.M., Santos, A.R.S., Caffeine at moderate doses can inhibit acupuncture-induced analgesia in a mouse model of postoperative pain. J Caff Res 3 (2013), 1–6.
123. Nakamura, I., Ohta, Y., Kemmotsu, O., Characterization of adenosine receptors mediating spinal sensory transmission related to nociceptive information in the rat. Anesthesiology 97 (1997), 577–584.
124. 2A receptor subtypes and protein kinase C pathways. J Pharmacol Exp Ther 334 (2010), 590–598.
125. Nesher, G., Mates, M., Zevin, S., Effect of caffeine consumption on efficacy of methotrexate in rheumatoid arthritis. Arth Rheum 48 (2003), 571–572.
126. 1 receptor agonist. Naunyn Schmiedeberg's Arch Pharmacol 350 (1994), 57–62.
127. Ochaion, A., Bar-Yehuda, S., Choen, S., Barer, F., Patoka, R., Amitil, H., Reitblat, T., Teitblat, A., Ophir, J., Konfino, I., Chowers, Y., Ben-Horin, S., Fishman, P., The anti-inflammatory target A3 adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease. Cell Immunol 258 (2009), 115–122.
128. Patel, M.K., Pinnock, R.D., Lee, K., Adenosine exerts multiple effects in dorsal horn neurones of the adult rat spinal cord. Brain Res 920 (2001), 19–26.
129. Paterniti, I., Melani, A., Cipriani, S., Corti, F., Mello, T., Masson, E., Esposito, E., Pl, Bramanti., Cuzzocrea, S., Pedata, F., Selective adenosine A2A receptor agonists and antagonists protect against spinal cord injury through peripheral and central effects. J Neuroinflamm, 8, 2011, 31, 10.1186/1742-2094-8-31.
130. 2A receptors in (−)-linalool-induced antinociception. Life Sci 78 (2006), 2471–2474.
131. Poon, A., Sawynok, J., Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat. Pain 74 (1998), 235–245.
132. 2A receptors in the central nervous system. CNS Neurol Disord Drug Targets 11 (2012), 644–674.
133. Racine, M., Tousignant-Laflamme, Y., Klodaa, L.A., Dion, D., Choniere, M., A systematic literature review of 10 years of research on sex-gender and pain perception – part 1: are there really differences between women and men?. Pain 153 (2012), 602–611.
134. 1 receptor agonist N6-cyclopentyl-adenosine (CPA) and opioid receptors in spinal cord nociceptive reflexes. Life Sci 93 (2013), 233–239.
135. 1 receptor agonist cyclopentyl-adenosine in rats with inflammation. Eur J Pharmacol 499 (2004), 247–256.
136. Rauck, R.L., North, J., Eisenach, J.C., Intrathecal clonidine and adenosine: effects on pain and sensory processing in patients with chronic regional pain syndrome. Pain 156 (2015), 88–95.
137. Reeve, A.J., Dickenson, A.H., The roles of spinal adenosine receptors in the control of acute and more persistent nociceptive responses of dorsal horn neurons in the anaesthetized rat. Brit J Pharmacol 116 (1995), 2221–2228.
138. Salter, M.W., De Koninck, Y., Henry, J.L., Physiological roles for adenosine and ATP in synaptic transmission in the spinal dorsal horn. Prog Neurobiol 41 (1993), 125–156.
139. 1 receptors mediate the presynaptic inhibition of calcitonin gene-related peptide release by adenosine in the rat spinal cord. Eur J Pharmacol 231 (1993), 139–142.
140. 2B receptor antagonist but not imidazoline receptor antagonists modulate antinociception induced by diphenyl diselenide in mice. Neurosci Lett 436 (2008), 120–123.
141. Sawynok, J., Adenosine receptor activation and nociception. Eur J Pharmacol 347 (1998), 1–11.
142. Sawynok, J., Methylxanthines and pain. Methylxanthines, Handbook of Experimental Pharmacology 200 (2011), 311–329.
143. Sawynok, J., Adenosine and pain. Masino, S., Boison, D., (eds.) Adenosine. A key link between metabolism and brain activity, 2013, Springer, 343–360.
144. Sawynok, J., Liu, X.J., Adenosine in the spinal cord and periphery: release and regulation of pain. Prog Neurobiol 69 (2003), 313–340.
145. Sawynok, J., Reid, A.R., Caffeine inhibits antinociception by acetaminophen in the formalin test by inhibiting spinal adenosine A1 receptors. Eur J Pharmacol 674 (2012), 248–254.
146. 1 receptors. Neurosci Lett 440 (2008), 181–184.
147. 1 receptors: insights using knockout mice. Neurosci Lett 473 (2010), 178–181.
148. 1 receptors contribute to antinociception by tramadol in the formalin test in mice. Eur J Pharmacol 714 (2013), 373–378.
149. 1 receptor partial agonists in neuropathic pain. Eur J Pharmacol 514 (2005), 131–140.
150. 1 receptor ligands: past, present and future trends. Curr Top Med Chem 10 (2010), 878–901.
151. Schmidt, A.P., Böhmer, A.E., Antunes, C., Schallenberger, C., Porciúncula, L.O., Elisabetsky, E., Lara, D.A., Souza, D.O., Antinociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1 adenosine receptors. Br J Pharmacol 156 (2009), 163–172.
152. Schmidt, A.P., Böhmer, A.E., Schallenberger, C., Antunes, C., Tavares, R.G., Woofchuk, S.T., Elisabetsky, E., Souza, D.O., Mechanisms involved in the antinociception induced by systemic administration of guanosine in mice. Br J Pharmacol 159 (2010), 1247–1263.
153. 1 receptors in the spinal cord dorsal horn, and relationship to primary afferents and neuronal subpopulations. Neuroscience 121 (2003), 907–916.
154. Sebastião, A.M., Cristóvão-Ferreira, S., Ribeiro, J.A., Downstream pathways of adenosine. Masino, S., Boison, D., (eds.) Adenosine. A Key Link Between Metabolism and Brain Activity, 2013, Springer, 131–156.
155. Segerdahl, M., Sollevi, A., Adenosine and pain relief: a clinical overview. Drug Dev Res 45 (1998), 151–158.
156. Sharma, M., Mohta, M., Chawla, R., Efficacy of intrathecal adenosine for postoperative pain relief. Eur J Anaesthesiol 23 (2006), 449–453.
157. Silverman, M.H., Strand, V., Markovits, D., Nahir, M., Reitblat, T., Moland, Y., Rosner, I., Rozenbaum, M., Mader, R., Adawi, M., Caspi, D., Tishler, M., Langevitz, P., Rubinow, A., Friedman, J., Green, L., Tanay, A., Cohaion, A., Cohen, S., Kerns, W.D., Cohn, I., Fishman-Furman, S., Farbstein, M., Yehuda, S.B., Fishman, P., Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial. J Rheumatol 35 (2008), 41–48.
158. Sneyd, J.R., Langton, J.A., Allan, L.G., Peacock, J.E., Rowbotham, D.J., Multicentre evaluation of the adenosine agonist GR79236X in patients with dental pain after third molar extraction. Br J Anaesth 98 (2007), 672–676.
159. Sorge, R.E., Mapplebeck, J.C.S., Rosen, S., Beggs, S., Taves, S., Alexander, J.K., Martin, L.J., Austin, J.S., Sotocinal, S.G., Chen, D., Yang, M., Shi, X.Q., Huang, H., Pillon, N.J., Bilan, P.J., Tu, Y.S., Klip, A., Ji, R.R., Zhang, J., Salter, M.W., Mogil, J.S., Different immune cells mediate mechanical pain hypersensitivity in male and female mice. Nature Neurosci 18 (2015), 1081–1083.
160. 9-tetrahydrocannabinol on spatial memory. Neuropsychopharmacol 36 (2011), 472–487.
161. Sowa, N.A., Street, S.E., Vihko, P., Zylka, M.J., Prostatic acid phosphatase reduces thermal sensitivity and chronic pain sensitization by depleting phosphatidylinositol 4,5-bisphosphate. J Neurosci 30 (2010), 10282–10293.
162. Sowa, N.A., Taylor-Blake, B., Zylka, M.J., Ecto-5’-nucleotidase (CD73) inhibits nociception by hydrolyzing AMP to adenosine in nociceptive circuits. J Neurosci 30 (2010), 2235–2244.
163. Sowa, N.A., Vadakkan, K.I., Zylka, M.J., Recombinant mouse PAP has pH-dependent ectonucleotidase activity and acts through A1-adenosine receptors to mediate antinociception. PLoS One, 4(1), 2009, e4248, 10.137/journal.pone.0004248.
164. 1 receptor activation. Molecular Pain, 6, 2010, 20, 10.1186/1744-8069-6-20.
165. Stagg, N.J., Mata, H.P., Ibrahim, M.M., Henricksen, E.J., Porreca, F., Vanderah, T.W., Malan, P., Regular exercise reverses sensory hypersensitivity in a rat neuropathic pain model: role of endogenous opioids. Anesthesiol 114 (2011), 940–948.
166. Stepanović-Petrović, R.M., Micov, A.M., Tomić, M.A., Ugrešić, N.D., The local peripheral antihyperalgesic effect of levetiracetam and its mechanism of action in an inflammatory pain model. Anesth Analg 115 (2012), 1457–1466.
167. Street, S.E., Kramer, N.J., Walsh, P.L., Taylor-Blake, B., Yadav, M.C., King, I.F., Vihko, P., Wightman, R.M., Miullan, J.L., Zylka, M.J., Tissue-nonspecific alkaline phosphatase acts redundantly with PAP and NT5E to generate adenosine in the dorsal spinal cord. J Neurosci 33 (2013), 11314–11322.
168. Suh, H.W., Song, D.K., Kim, Y.H., Differential effects of adenosine receptor antagonists injected intrathecally on antinociception induced by morphine and β-endorphin administered intracerebroventricularly in the mouse. Neuropeptides 31 (1997), 339–344.
169. Swanson, D.L., Barnes, S.A., Mengden Koon, S.J., el-Azhary, R.A., Caffeine consumption and methotrexate dosing requirement in psoriasis and psoriatic arthritis. Int J Derm 46 (2007), 157–159.
170. Sweeney, M.I., White, T.D., Sawynok, J., Involvement of adenosine in the spinal antinociceptive effects of morphine and noradrenaline. J Pharmacol Exp Ther 243 (1987), 657–665.
171. Taiwo, Y.O., Levine, J.D., Direct cutaneous hyperalgesia induced by adenosine. Neuroscience 38 (1990), 757–762.
172. Takano, T., Chen, X.C., Luo, F., Fujita, T., Ren, Z., Goldman, N., Zhao, Y., Markman, J.D., Nedergaard, M., Traditional acupuncture triggers a local increase in adenosine in human subjects. J Pain 13 (2012), 1215–1223.
173. Taylor-Blake, B., Zylka, M.J., Prostatic acid phosphatase is expressed in peptidergic and nonpeptidergic nociceptive neurons of mice and rats. PLoS One, 5, 2010, e8674, 10.1371/journal.pone.0008674.
174. Tian, L., Ji, G., Wang, C., Bai, X., Lu, Y., Xiong, L., Excitatory synaptic transmission in the spinal substantia gelatinosa is under an inhibitory tone of endogenous adenosine. Neurosci Lett 477 (2010), 28–32.
175. Tomić, M.A., Pecikoza, U.B., Micov, A.M., Popović, B.V., Stepanović-Pertović, R.M., The effects of levetiracetam, sumatriptan, and caffeine in a rat model of trigeminal pain: interactions in 2-component combinations. Anesth Analg 120 (2015), 1385–1393.
176. Tomić, M.A., Vučkovic, S.M., Stepanović-Petrović, M., Ugrešić, N., Prostran, M.S., Bošković, B., The anti-hyperalgesic effects of carbamazepine and oxcarbazepine are attenuated by treatment with adenosine receptor antagonists. Pain 111 (2004), 253–260.
177. Tomić, M.A., Vučkovic, S.M., Stepanović-Petrović, M., Ugrešić, N., Prostran, M.S., Bošković, B., Peripheral anti-hyperalgesia by oxcarbazepine: involvement of adenosine A1 receptors. Pharmazie 61 (2006), 566–568.
178. Ulugol, A., Karadag, H.C., Tamer, M., Firat, Z., Aslantas, A., Dokmeci, I., Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats. Neurosci Lett 328 (2002), 129–132.
179. Vacca, V., Marinelli, S., Pieroni, L., Urbani, A., Luvisetto, S., Pavone, F., Higher pain perception and lack of recovery from neuropathic pain in females: a behavioural, immunohistochemical, and proteomic investigation on sex-related differences in mice. Pain 155 (2014), 388–402.
180. 1 receptors. Br J Pharmacol 158 (2009), 558–568.
181. Vance, C.G.T., Dailey, D.L., Rakel, B.A., Sluka, K.A., Using TENS for pain control: the state of the evidence. Pain Management 4 (2014), 197–209.
182. Varani, K., Padovan, M., Govoni, M., Vincenzi, F., Trotta, F., Borea, P.A., The role of adenosine receptors in rheumatoid arthritis. Autoimmunity Rev 10 (2010), 61–64.
183. 3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release. Arth Res Ther, 13, 2011, R198, 10.1186/ar3527.
184. 3 adenosine receptors reduces bone-residing breast cancer in a rat preclinical model. Eur J Cancer 49 (2013), 482–491.
185. 2A adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats. PLoS One, 8(1), 2013, e54195, 10.1371/journal.pone.0054195.
186. 1 adenosine receptor allosteric modulator, exhibits antinociceptive properties in acute and neuropathic pain models in mice. Neuropharmacol 81 (2014), 6–14.
187. Vučković, S., Tomić, M., Stepanović-Petrović, R., Ugrešic, N., Prostran, M., Boškovic, B., Peripheral antinociception by carbamazepine in an inflammatory mechanical hyperalgesia model in the rat: a new target for carbamazepine. J Pharmacol Sci 100 (2006), 310–314.
188. Wu, S.Y., Chen, W.H., Hsieh, C.L., Lin, Y.W., Abundant expression and functional participation of TRPV1 at Zusanli acupoint (ST36) in mice: mechanosensitive TRPV1 as an “acupuncture-responding channel”. BMC Comp Alt Med, 14, 2014, 96, 10.1186/1472-6882-14-96.
189. 3 receptors. Neuroscience 114 (2002), 523–527.
190. 1 receptor. Pain 113 (2005), 395–404.
191. Yaba, G., Sezer, S., Tekol, Y., Interaction between venlafaxine and caffeine on antinociception in mice. Pharmazie 61 (2006), 60–62.
192. Yamaoka, G., Horiuchi, H., Morino, T., Miura, H., Ogata, T., Different analgesic effects of adenosine between postoperative and neuropathic pain. J Orthop Sci 18 (2013), 130–136.
193. 2A adenosine receptor genes show similarities to mice given long-term caffeine. J Appl Physiol 106 (2009), 631–639.
194. 2A adenosine receptors in regulating heart rate, body temperature, and locomotion using knockout mice and caffeine. Am J Physiol Heart Circ Physiol 296 (2009), H1141–H1149.
195. Yoon, M.H., Bae, H.B., Choi, J.I., Antinociception of intrathecal adenosine receptor subtype agonists in rat formalin test. Anesth Analg 101 (2005), 1417–1421.
196. Yoon, M.H., Bae, H.B., Choi, J.I., Kim, S.J., Chung, S.T., Kim, C.M., Roles of adenosine receptor subtypes in the antinociceptive effect of intrathecal adenosine in a rat formalin test. Pharmacology 78 (2006), 21–26.
197. 2a receptor agonist reduces hyperalgesia caused by a surgical incision in rats. A pertussis toxin-sensitive G protein-dependent process. Anesthesiology 107 (2007), 797–806.
198. Zakaria, Z.A., Mohd Sani, M.H., Chemma, M.S., Kader, A.A., Kek, T.L., Salleh, M.Z., Antinociceptive activity of methanolic extract of Muntingia calabura leaves: further elucidation of the possible mechanisms. BMC Complement Altern Med, 14, 2014, 63, 10.1186/1472-6882-14-63.
199. Zárate, E., Sa Rego, M.M., White, P.F., Duffy, L., Shearer, V.E., Griffin, J.D., Whitten, C.W., Comparison of adenosine and remifentanil infusions as adjuvants to desflurate anesthesia. Anesthesiology 90 (1999), 956–963.
200. Zhang, X.J., Chen, H.L., Li, Z., Shang, H.Q., Sung, J.L., Bian, Z.X., Analgesic effect of paeoniflorin in rats with neonatal maternal separation-induced visceral hyperalgesia is mediated through adenosine A(1) receptor by inhibiting the extracellular signal-regulated protein kinase (ERK) pathway. Pharmacol Biochem Behav 94 (2009), 88–97.
201. Zhao, Z.Q., Neural mechanisms underlying acupuncture analgesia. Prog Neurobiol 85 (2008), 355–375.
202. Zylka, M.J., Pain-relieving prospects for adenosine receptors and ectonucleotidases. Trends Mol Med 17 (2011), 188–196.
203. Zylka, M.J., Sowa, N.A., Taylor-Blake, B., Twomey, M.A., Herrala, A., Voikar, V., Vihko, P., Prostatic acid phosphatase is an ectonucleotidase and suppresses pain by generating adenosine. Neuron 60 (2008), 111–122.